Successful hematopoietic stem cell mobilization and apheresis collection using plerixafor alone in sickle cell patients

Novel therapies for sickle cell disease (SCD) based on genetically engineered autologous hematopoietic stem and progenitor cells (HSPCs) are critically dependent on a safe and effective strategy for cell procurement. We sought to assess the safety and efficacy of plerixafor when used in transfused p...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Blood Adv
Autori principali: Esrick, Erica B., Manis, John P., Daley, Heather, Baricordi, Cristina, Trébéden-Negre, Hélène, Pierciey, Francis J., Armant, Myriam, Nikiforow, Sarah, Heeney, Matthew M., London, Wendy B., Biasco, Luca, Asmal, Mohammed, Williams, David A., Biffi, Alessandra
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society of Hematology 2018
Soggetti:
Clinical Trials and Observations
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6177648/
https://ncbi.nlm.nih.gov/pubmed/30282642
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2018016725
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi